Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For WELL
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -13.92 3.83 4.45
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -19.25 16.94 20.98
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.69 47.99 46.28
Cash 14.14 4.32 3.78
Capex 30.99 -0.23 -0.33
Free Cash Flow 7.06 0.47 0.44
Revenue 1.63 3.24 3.19
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -29.52 0.21 -0.30
Operating Margin -42.87 0.19 -0.33
ROA 49.68 < 0.005 < 0.005
ROE 39.73 < 0.005 < 0.005
ROIC -45.72 < 0.005 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of WELL is permitted for members.
5 Growth
The "Growth Entry" for the Focus of WELL is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of WELL is permitted for members.